• EVALUATION

    2026 Annual Meeting of the Florida Society of Neurology
    Neurodegenerative Disease, Movement Disorders, Dementia

    Saturday, January 17, 2026 – Sunday, January 18, 2026

  • What best describes your title?*
  • What best describes your specialty?
  • 1. Which of the following medications is FDA approved for treatment of juvenile myasthenia gravis?*
  • 2. What is the mechanism of action of FcRn blockers?*
  • Please rate your experience at the activity:
    Rows
  • Please rate the extent to which this activity met the following objectives:
    Rows
  • Which of the following strategies do you plan to implement in your practice? (Select all that apply)
  • Which of the following barriers do you foresee to making a change in your practice? (Select all that apply)
  • Has this education enhanced your role as a member of the healthcare team?
  • Should be Empty: